UBS ASSET MANAGEMENT AMERICAS LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 240 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2022. The put-call ratio across all filers is 0.45 and the average weighting 1.6%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$9,673,670,000
-80.4%
63,992
-81.1%
0.01%
-80.8%
Q2 2022$49,354,016,000
+586.7%
338,714
+458.8%
0.03%
+766.7%
Q1 2022$7,187,239,000
-7.5%
60,616
+7.5%
0.00%0.0%
Q4 2021$7,769,314,000
+1.8%
56,377
+2.7%
0.00%0.0%
Q3 2021$7,628,521,000
+44.6%
54,917
+1.0%
0.00%
+50.0%
Q2 2021$5,276,687,000
+48.2%
54,354
+4.3%
0.00%0.0%
Q1 2021$3,561,708,000
-16.2%
52,103
+5.1%
0.00%0.0%
Q4 2020$4,249,930,000
+45.4%
49,585
+10.3%
0.00%0.0%
Q3 2020$2,922,720,000
-10.5%
44,958
+0.6%
0.00%0.0%
Q2 2020$3,266,189,000
+87.8%
44,675
-12.6%
0.00%
+100.0%
Q1 2020$1,739,615,000
-40.2%
51,120
-4.3%
0.00%
-50.0%
Q4 2019$2,907,368,000
-64.0%
53,405
-72.4%
0.00%
-60.0%
Q3 2019$8,083,583,000
+3.2%
193,758
+8.4%
0.01%
-16.7%
Q2 2019$7,830,352,000
+2101.0%
178,816
+2487.0%
0.01%
Q1 2019$355,761,000
+39.2%
6,9120.0%0.00%
Q4 2018$255,606,000
+3.1%
6,912
+4.7%
0.00%
Q3 2018$247,830,0006,6000.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders